<p>Compounds that shows inhibition of PTP1B at 1.25 μM concentration in <i>in vitro</i> assays.</p
<p>Inhibition concentrations of Compound 29 and Chloroquine in strains producing different levels of...
<p>Inhibition of tested proteases by compounds Camostat, “Novartis166” and “Novartis848”.</p
The present invention provides compounds of Formula (I) and Formula (II) that are useful for modulat...
<p>Inhibition of PARP activity by selected seven compounds whose tested concentrations were 0.1 µM, ...
<p>A) A panel of 32 compounds was evaluated for the ability to inhibit TcPARP activity <i>in vitro</...
<p>The examined test compounds for TS inhibition, their reference numbers, structures, and manufactu...
<p>Lineweaver-Burk double-reciprocal plots representing inhibitory profiles of compounds KuwE, PirII...
<p><i>In-vitro</i> antibacterial activities of inhibitors of PBPs from resistant species.</p
(A) The structure of PEITC. (B) Concentration-dependent inhibition of PTP1B by PEITC. Recombinant PT...
<p>Compounds tested as inhibitors of the NF-κB:DNA-recognition target complex formation.</p
a<p>Viability was assessed by an MTT assay at 48 hrs of incubation over a series of doubling dilutio...
<p><i>In vitro</i> inhibitory effects of compounds 1a-2b against the proliferation of three human ca...
<p>(<b>A</b>) Inhibition potencies of the candidate compounds. The magnitudes of inhibition by compo...
<p>The inhibition and inactivation kinetic parameters of PTPase in the presence of urea and GdnHCl.<...
The present invention provides compounds of Formula (I) and Formula (II) that are useful for modulat...
<p>Inhibition concentrations of Compound 29 and Chloroquine in strains producing different levels of...
<p>Inhibition of tested proteases by compounds Camostat, “Novartis166” and “Novartis848”.</p
The present invention provides compounds of Formula (I) and Formula (II) that are useful for modulat...
<p>Inhibition of PARP activity by selected seven compounds whose tested concentrations were 0.1 µM, ...
<p>A) A panel of 32 compounds was evaluated for the ability to inhibit TcPARP activity <i>in vitro</...
<p>The examined test compounds for TS inhibition, their reference numbers, structures, and manufactu...
<p>Lineweaver-Burk double-reciprocal plots representing inhibitory profiles of compounds KuwE, PirII...
<p><i>In-vitro</i> antibacterial activities of inhibitors of PBPs from resistant species.</p
(A) The structure of PEITC. (B) Concentration-dependent inhibition of PTP1B by PEITC. Recombinant PT...
<p>Compounds tested as inhibitors of the NF-κB:DNA-recognition target complex formation.</p
a<p>Viability was assessed by an MTT assay at 48 hrs of incubation over a series of doubling dilutio...
<p><i>In vitro</i> inhibitory effects of compounds 1a-2b against the proliferation of three human ca...
<p>(<b>A</b>) Inhibition potencies of the candidate compounds. The magnitudes of inhibition by compo...
<p>The inhibition and inactivation kinetic parameters of PTPase in the presence of urea and GdnHCl.<...
The present invention provides compounds of Formula (I) and Formula (II) that are useful for modulat...
<p>Inhibition concentrations of Compound 29 and Chloroquine in strains producing different levels of...
<p>Inhibition of tested proteases by compounds Camostat, “Novartis166” and “Novartis848”.</p
The present invention provides compounds of Formula (I) and Formula (II) that are useful for modulat...